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Summary
 
The B cell antigen receptor (BCR) serves both to initiate signal transduction cascades and to
target antigen for processing and presentation by MHC class II molecules. How these two
BCR functions are coordinated is not known. Recently, sphingolipid- and cholesterol-rich
plasma membrane lipid microdomains, termed lipid rafts, have been identified and proposed to
function as platforms for both receptor signaling and membrane trafficking. Here we show that
 
upon cross-linking, the BCR rapidly translocates into ganglioside G
 
M1
 
-enriched lipid rafts that
 
contain the Src family kinase Lyn and exclude the phosphatase CD45R. Both Ig
 
a 
 
and Lyn in
the lipid rafts become phosphorylated, and subsequently the BCR and a portion of G
 
M1 
 
are tar-
geted to the class II peptide loading compartment. Entry into lipid rafts, however, is not suffi-
cient for targeting to the antigen processing compartments, as a mutant surface Ig containing a
deletion of the cytoplasmic domain is constitutively present in rafts but when cross-linked does
not internalize to the antigen processing compartment. Taken together, these results provide
evidence for a role for lipid rafts in the initial steps of BCR signaling and antigen targeting.
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T
 
he B cell antigen receptor (BCR)
 
1
 
 is a multicomponent
complex on the cell surface that is composed of a cell
surface (s)Ig that mediates antigen binding and a nonco-
valently associated heterodimer, Ig
 
a
 
/Ig
 
b
 
, that functions as
a signal transduction complex (for review see reference 1).
After antigen binding and cross-linking, the BCR transmits
signals through several signaling pathways that result in the
expression of a variety of genes associated with B cell acti-
vation. Early key events in the BCR signal transduction
cascade include the activation of protein tyrosine kinases of
the Src and Syk/Zap70 families and the phosphorylation of
tyrosine residues in the immune receptor tyrosine-based
activation motifs (ITAMs) in the cytoplasmic domains of
Ig
 
a 
 
and Ig
 
b 
 
(1–3).
Although necessary for the activation of B cells, the sig-
nals transmitted through the BCR alone are not sufficient
to induce the proliferation and differentiation of B cells.
The B cell antibody response to the vast majority of protein
antigens requires B cell interaction with antigen-specific T
cells (for review see reference 4). The interactions of B cells
and helper T cells are dependent on the processing and
presentation of antigen by B cells to the helper T cells (5).
The BCR plays an important role in antigen processing by
targeting bound antigen to the class II peptide loading com-
partment (IIPLC; for review see reference 6). Indeed, BCR-
mediated antigen processing is thousandsfold more efficient
in B cells compared with the processing of antigen taken
up nonspecifically by fluid phase pinocytosis.
 
Recent evidence indicates that the two functions of
 
the BCR, signaling and antigen targeting, are interrelated (7).
Monovalent antigens bound to the BCR are processed and
presented, but less efficiently than multivalent antigens (8).
Cross-linking the BCR results in internalization of a larger
number of receptors and a significant acceleration of the
targeting of the BCR to the IIPLC and of the degradation
of BCR and bound antigen (9). The accelerated delivery of
antigen to the IIPLC may play an important role in vivo
during periods of rapid antigen-driven B cell expansion and
T cell–dependent selection. The effects of BCR cross-link-
 
ing appear to be the result of BCR signaling rather than ag-
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Abbreviations used in this paper:
 
 BCR, B cell antigen receptor; CM, com-
plete media; CTB, cholera toxin B subunit; ECL, enhanced chemilumi-
nescence; GPI, glycosylphosphatidylinositol; HRP, horseradish peroxi-
dase; ITAMs, immune receptor tyrosine-based activation motifs; PI-PLC,
phosphatidylinositol-specific phospholipase C; sIg, cell surface Ig; TfR,
transferrin receptor; WT, wild-type. 
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gregation of the BCR because kinase inhibitors that block
BCR signaling block accelerated targeting and degradation
(10). In addition, Aluvihare et al. (11) recently showed that
accelerated antigen targeting by the BCR is dependent on
Ig
 
a 
 
and Ig
 
b
 
. Further evidence for an important role of Ig
 
a
 
/
Ig
 
b 
 
in BCR antigen targeting was demonstrated by the be-
havior of two mutant Igs that do not associate with Ig
 
a
 
/
Ig
 
b
 
 (12). An sIg in which the short, three–amino acid cyto-
plasmic domain was deleted (
 
m
 
Cyto
 
D
 
) was expressed on
the cell surface without Ig
 
a
 
/Ig
 
b
 
. The 
 
m
 
Cyto
 
D
 
 was glyco-
sylphosphatidylinositol (GPI) linked (13) and, after antigen
binding, failed to internalize and target antigen to the IIPLC
(12). Another sIg in which Y
 
587
 
 and S
 
588
 
 in the transmem-
brane region was changed to VV (
 
m
 
YS/VV) was also ex-
pressed on the cell surface in the absence of Ig
 
a
 
/Ig
 
b
 
 (14).
 
m
 
YS/VV was competent to internalize bound antigen and,
although the antigen was degraded, it was not presented by
the class II molecules, suggesting that correct targeting of the
BCR to the IIPLC was dependent on Ig
 
a
 
/Ig
 
b
 
 (15). An-
other sIg containing a single Y
 
587
 
®
 
F transmembrane muta-
tion that associated with Ig
 
a
 
/Ig
 
b
 
 was signaling competent
but like 
 
m
 
YS/VV did not target antigen for processing. Thus,
both the signaling function and the nature of the sIg trans-
membrane region appear to dictate the behavior of the
BCR, that is, to specify the correct targeting of the BCR
to the IIPLC and to accelerate the rate at which the antigen
is targeted to the IIPLC. At the time of this writing, the mo-
lecular mechanisms by which the targeting and signaling
functions of the BCR are coordinated after antigen binding
and receptor cross-linking on the cell surface are not known.
Recent advances in membrane biology have led to the
identification of glycosphingolipid- and cholesterol-rich
plasma membrane microdomains, or lipid rafts, that have
been proposed to function as platforms for both signal trans-
duction and membrane trafficking (for review see reference
16). Lipid rafts can be isolated based on their insolubility in
Triton X-100 detergent and buoyant density on sucrose
gradients (17–20). Several proteins have been identified as
residents of these lipid microdomains, including caveolin
(21), GPI-linked membrane proteins (17, 22), influenza
hemagglutinin (23), the high-affinity IgE receptor (24, 25),
and the B cell integral membrane protein CD20 (26). In
addition, several molecules involved in signal transduction
have been shown to be associated with lipid rafts such as
the G
 
a 
 
subunits of heterotrimeric G proteins (27), the double-
acylated Src family protein tyrosine kinases Lck, Lyn, and
Fyn (28), and the Zap70 family protein tyrosine kinase, Syk
(25). The lipid rafts are also associated with actin and actin-
binding proteins (29, 30).
Immunofluorescence microscopy (22, 31), fluorescence
resonance energy transfer (32), and chemical cross-linking
studies (21, 33) have led to the proposal that rafts are not
static entities in situ but instead dynamic microdomains on
the cell surface to which proteins and lipids have variable
affinities (34). In this way, certain signals such as the cross-
linking of a membrane protein may affect its distribution in
raft domains (35). Indeed, it has been shown recently that
upon cross-linking the TCR, its associated signaling mole-
 
cules and coreceptors acquire increased affinities toward lipid
rafts (36–40) and that the integrity of these domains is required
for efficient signal transduction by the TCR (37). Here we
provide evidence for a role for lipid rafts in BCR signaling
and antigen targeting.
 
Materials and Methods
 
Cell Lines and Antibodies.
 
The mouse B cell lymphoma CH27
(H-2
 
k
 
, IgM
 
1
 
, Fc
 
g
 
RIIB1
 
2
 
) was maintained in DME supple-
mented as previously described (41) and containing 15% FCS
(15% complete media [CM]). The A20 B lymphoma line (H-2
 
d
 
,
IgG
 
2a
 
1
 
, Fc
 
g
 
RIIB1
 
1
 
) stably transfected with either a human 
 
m
 
wild-type (A20
 
m
 
WT) or a mutation that generated a premature
stop codon at amino acid K
 
595
 
, resulting in the deletion of the
cytoplasmic tail (A20
 
m
 
Cyto
 
D
 
; reference 12), was maintained in
15% CM containing 600 
 
m
 
g/ml G418.
Goat Fab anti–mouse 
 
m 
 
chain; rabbit anti–human IgG plus
IgM (H and L chain); horseradish peroxidase (HRP)-conjugated
goat anti–mouse IgG plus IgM (H
 
 
 
and L chain); HRP-conjugated
rabbit F(ab
 
9
 
)
 
2
 
 anti–mouse 
 
g
 
 chain and anti–human 
 
m 
 
chain; and
FITC-conjugated goat anti–mouse 
 
g
 
 chain, anti–human 
 
g
 
 chain,
and anti–human 
 
m
 
 chain were purchased from Jackson Immu-
noResearch. Cholera toxin B subunit (CTB) conjugated to HRP
and methyl-
 
b
 
-cyclodextrin were obtained from Sigma Chemical
Co. Antibodies specific for mouse CD45R and Lyn were ob-
tained from PharMingen. The goat polyclonal antibody specific
for actin was obtained from Santa Cruz Biotechnology, and the
rat mAb YL1/2 specific for tubulin (42) was a gift from Dr. Dou-
glas T. Fearon (University of Cambridge, UK). RC20H phos-
photyrosine-specific recombinant antibody conjugated to HRP
was purchased from Transduction Labs. Polyclonal antibodies
specific for H2-M were generated in rabbits using a peptide rep-
resenting the cytoplasmic tail domain of H2-M (residues 224–
245) containing a T cell epitope derived from tetanus toxoid (resi-
dues 582–599). The mouse IgG
 
2a
 
 hybridoma 17.3.3s producing
an mAb specific for I-E
 
k
 
, the mouse IgG
 
2a
 
 hybridoma HB3
(MK-D6) producing an mAb specific for I-A
 
d
 
, and the rat IgG
 
2a
 
hybridoma RI7 217.1.3 producing an mAb specific for the trans-
ferrin receptor (TfR) were obtained from the American Tissue
Type Culture Collection. The rat hybridoma 79a3, producing an
IgG
 
1 
 
mAb specific for the cytosolic domain of mouse Ig
 
a
 
,
 
 
 
was gen-
erated and characterized in the Pierce laboratory at Northwestern
University. All hybridomas were maintained in the Pierce labora-
tory, and mAbs were purified from culture supernatant by affinity
chromatography.
Goat Fab anti–mouse 
 
m 
 
was iodinated using the iodine mono-
chloride method to a specific activity of 0.5–1.0 
 
3
 
 10
 
7
 
 cpm/
 
m
 
g
as described (43). More than 85% of the 
 
125
 
I–Fab was precipitated
by 10% TCA, indicating little free 
 
125
 
I. Unlabeled Fab competed
with 
 
125
 
I–Fab for binding to the surface of CH27 cells, indicating
that iodination did not affect the binding properties of the Fab.
 
Isolation of Lipid Rafts.
 
Lipid rafts were isolated using modi-
fied lysis conditions and flotation on discontinuous sucrose gradi-
ents (20, 36, 37). In brief, cells (10
 
8
 
) were washed with ice-cold
PBS and lysed for 30 min on ice in 1% Triton X-100 in TNEV
containing protease and phosphatase inhibitors (TNEV: 10 mM
Tris/HCl, pH 7.5, 150 mM NaCl, and 5 mM EDTA; CLAP [2.5
mg/ml each of chymostatin, leupeptin, antipain, and pepstatin A
in DMSO] and 1 mM sodium orthovanadate). The lysis solution
was further homogenized with ten strokes in a Wheaton loose-
fitting dounce homogenizer. Nuclei and cellular debris were pel- 
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leted by centrifugation at 900 
 
g
 
 for 10 min. For the discontinuous
sucrose gradient, 1 ml of cleared supernatant was mixed with 1 ml
of 85% sucrose in TNEV and transferred to the bottom of a
Beckman 14 
 
3
 
 89 mm centrifuge tube. The diluted lysate was
overlaid with 6 ml 35% sucrose in TNEV and finally 3.5 ml 5%
sucrose in TNEV. The samples were centrifuged in an SW41 ro-
tor at 200,000 
 
g
 
 for 16–20 h at 4
 
8
 
C. 1-ml fractions were collected
from the top of the gradient.
 
Measurement of HRP Activity.
 
A 50-
 
m
 
l sample of each frac-
tion from the discontinuous sucrose gradient was incubated with
50 
 
m
 
l of substrate solution (5 mg/ml 2,2-azino-bis-3-ethylbenz-
thiazoline-6-sulfonic acid in 0.1 M citrate-phosphate buffer, pH
4.0, with 0.015% H
 
2
 
O
 
2
 
). The absorbence was measured at 405 nm
on an ELISA plate reader.
 
Surface Biotinylation and Metabolic Labeling.
 
Cells (2 
 
3
 
 10
 
8
 
) were
washed with ice-cold HBSS
 
1
 
 (13 mM CaCl
 
2
 
, 50 mM KCl, 5 mM
MgCl
 
2
 
.6H
 
2
 
O, 4 mM MgSO
 
4
 
, 1.38 M NaCl, 56 mM glucose,
and 200 mM Hepes, pH 7.4) and incubated in 0.2 mg/ml
 
N
 
-hydroxysuccinimide long chain–biotin (Pierce Chemical Co.)
in HBSS
 
1
 
 for 15 min at 4
 
8
 
C. Additionally, an equal volume of
0.2 mg/ml biotin was added, and incubation at 4
 
8
 
C was con-
tinued for another 15 min. The biotinylation reaction was
quenched with ice-cold DME/BSA, washed extensively, and re-
suspended in 5 ml DME/BSA. For metabolic labeling, cells (2 
 
3
 
10
 
8
 
) were starved for 30 min in Met
 
2
 
/Cys
 
2
 
 DME with 5% dialyzed
FCS (5% labeling media) and labeled for 15 min with 200 
 
m
 
Ci/ml
 
35
 
S–70% methionine/30% cysteine (NEN Express).
 
HRP–3,39-Diaminobenzidine Reaction. Cells were washed twice
with ice-cold HBSS1 and resuspended in 1 ml of 0.5 mg/ml
3,39-diaminobenzidine (DAB) in HBSS1 with or without 0.1%
H2O2. The cells were incubated for 45 min at 48C, washed with
ice-cold HBSS1, and lysed in 1 ml of lysis buffer for 30 min on
ice. For studies on class II colocalization, 1% Triton X-100 lysis
buffer was used (1% Triton X-100, 50 mM Tris/HCl, pH 7.4,
150 mM NaCl, 5 mM EDTA, 0.02% sodium azide, and CLAP).
For studies on colocalization with biotinylated surface proteins,
RIPA lysis buffer was used (1% Triton X-100, 0.5% deoxycho-
late, and 0.1% SDS in PBS with 0.02% sodium azide and CLAP).
Cellular debris and aggregated protein polymers were pelleted
from the lysate with a 30-min 14,000 g microfuge spin before
immunoprecipitation.
Treatment of Cells with Phosphatidylinositol-specific Phospholipase C.
Cells (107) were surface biotinylated as described above and
washed twice in ice-cold PBS. Phosphatidylinositol-specific phos-
pholipase C (PI-PLC; Sigma Chemical Co.) was added at a con-
centration of 1 U/ml PBS and incubated at 378C for 1 h. Cells
were pelleted and the supernatant collected. The cells were then
washed twice with ice-cold PBS before lysis in 1 ml 1% Triton
X-100 lysis buffer. The lysates were cleared of debris as described
above. The cell lysates and the supernatants were immunopre-
cipitated for human Ig, and biotinylated material was visualized
by immunoblotting as described below.
Immunoprecipitation and Immunoblotting. Cell lysates were pre-
cleared of nonspecific proteins and endogenous Ig by incubation
with a 30% slurry of protein A–Sepharose or protein G–Sepharose
(Amersham Pharmacia Biotech) at 48C for 1 h. Antibodies (10
mg) and beads (50 ml) were added to the cleared lysate and incu-
bated overnight. The beads were washed three times with lysis
buffer and once with PBS. Samples were eluted from the beads
by either reducing and boiling for 5 min or incubating with a
cocktail lacking reducing agent at room temperature for 30 min.
The samples were subjected to 10% SDS-PAGE. Gels with meta-
bolically labeled samples were dried and exposed to film, and gels
with biotinylated samples were transferred onto Millipore Immo-
bilon PVDF (polyvinylidene difluoride) membrane. The mem-
branes were blocked for 1 h at 258C in a buffer containing 0.5%
Tween-20, 18% glucose, and 10% glycerol in PBS (TGG) with
3% milk and 1% BSA. The blots were washed in PBS/0.1%
Tween-20. A 1:1000 dilution of streptavidin–HRP (Amersham
Pharmacia Biotech) in TGG containing 0.3% BSA was added and
incubated at 258C for 1 h. After washing with PBS/Tween-20,
the blots were visualized with enhanced chemiluminescence
(ECL; Amersham Pharmacia Biotech). All films were quantified
by densitometry.
Results
Cross-linking the BCR Results in its Rapid Translocation into
Lipid Rafts. The present evidence indicates that the plasma
membrane contains sphingolipid- and cholesterol-enriched
microdomains, or lipid rafts, proposed to play a role in
membrane trafficking and signal transduction. These micro-
domains are resistant to Triton X-100 detergent solubiliza-
tion, allowing for their isolation in discontinuous sucrose
density gradients. The location of the BCR in unactivated
B cells and after BCR cross-linking with regard to lipid
rafts was determined. The CH27 B lymphoma cells that
were surface biotinylated were either untreated or treated
with anti-Ig at 48C for 15 min, washed, and warmed to
378C for 0 or 30 min. The cells were lysed in 1% Triton
X-100 lysis buffer on ice, and the lysates were subjected to
discontinuous sucrose density gradient centrifugation. Indi-
vidual fractions from the gradient were subjected to SDS-
PAGE and immunoblotting. The position of the lipid rafts
in the sucrose gradient was determined by the presence of
the ganglioside GM1, detected using GM1-specific ligand
CTB (Fig. 1). As shown in Fig. 1, GM1 is enriched in the
fractions at the top of the sucrose gradient, fractions 3–6.
There was no detectable GM1 in fractions 7–9 and only a
small amount of GM1 in the solubilized material located at
the bottom of the gradient, fractions 10–12, indicating a
clear separation of the lipid rafts from the Triton X-100–
soluble membranes and components. To determine where
in the gradients the BCR resided, immunoblots were
probed with antibodies specific for mouse IgM and an mAb
specific for Iga. In untreated cells, Ig and Iga were found
in the soluble fractions of the sucrose gradient and not in
the detergent-insoluble lipid raft region, indicating that in
resting cells the BCR is excluded from the lipid rafts (Fig.
1). After BCR cross-linking, a significant portion of both
the Ig and Iga are translocated into the lipid raft regions of
the sucrose gradient. Both Ig and Iga are present in the
lipid rafts immediately after cross-linking and warming to
378C. Somewhat less Ig and Iga are detected in the lipid
raft region 30 min after cross-linking.
To determine where in the gradient fractions the surface
BCR resided, the position of biotinylated sIg and sIga was
examined. The biotinylated CH27 lymphoma cells were
either untreated or treated with anti-Ig and analyzed as de-
scribed above. Biotinylated proteins were immunoprecipi-
tated from the Triton X-100 detergent lysates using strepta-1552 Role for Lipid Rafts in B Cell Receptor Signaling and Antigen Targeting
vidin–agarose, and the immunoprecipitates were analyzed
by SDS-PAGE and immunoblot probing with antibodies
specific for Ig or Iga. The distribution of the surface BCR
is similar to that observed for total cellular BCR. In the ab-
sence of anti-Ig cross-linking, the biotinylated sIg is excluded
from the lipid raft and is found in the detergent-soluble re-
gion of the gradient. Immediately upon cross-linking, the
biotinylated sIg is found in the raft region, where it persists
for at least 30 min. The behavior of biotinylated sIga is
similar to that of sIg, being excluded from lipid rafts in the
absence of cross-linking by anti-Ig and included in lipid
rafts upon cross-linking. Thus, cross-linking the BCR with
anti-Ig results in the rapid translocation of the surface BCR
into plasma membrane lipid rafts.
Lipid Rafts Include the Kinase Lyn and Exclude the Phos-
phatase CD45R. The results of experiments described above
indicate that upon cross-linking, the BCR is rapidly trans-
located into lipid rafts. As stated above, BCR cross-linking
results in the initiation of a signal transduction cascade in-
volving the phosphorylation of Iga/Igb ITAM tyrosines.
The Src family kinase Lyn is an essential protein tyrosine
kinase involved in the initial phosphorylation events. The
BCR response is ultimately terminated by dephosphoryla-
tion of BCR signaling components involving plasma mem-
brane phosphatases such as CD45R. Thus, the location of
Lyn and CD45R in membrane fractions was determined in
unactivated and activated B cells. B cells were untreated or
incubated with anti-Ig at 48C for 30 min, washed, and
warmed to 378C for 0 or 30 min. The cells were lysed in
1% Triton X-100 lysis buffer and subjected to discontinu-
ous sucrose gradient centrifugation, and the gradient frac-
tions were analyzed by SDS-PAGE and immunoblotting
for the presence of Lyn and CD45R. The kinase Lyn is
concentrated in the lipid raft region of the gradient in rest-
ing cells and remains in rafts after BCR cross-linking, at least
for the 30-min time course of this experiment (Fig. 2). In
contrast, the phosphatase CD45R is excluded from the
lipid rafts in resting cells and remains excluded after BCR
cross-linking (Fig. 2). The location of H2-M, a class II–like
protein that at steady state has been shown to reside prima-
rily in the IIPLC in CH27 cells (44), was also determined.
As anticipated, H2-M was found in the Triton X-100–sol-
uble membrane fractions in resting cells, and its presence in
soluble membranes did not change upon BCR cross-link-
ing. A portion of the cytoskeleton protein actin was found
to be constitutively associated with lipid rafts (Fig. 2). In con-
trast, tubulin was found to be completely excluded from the
lipid rafts in both anti-Ig–treated and untreated cells.
Phosphorylated Iga and Lyn Are Present in Lipid Rafts after
BCR Cross-linking. The presence of Lyn in the lipid raft
suggests that the Iga present in the lipid rafts after BCR
cross-linking may be phosphorylated. To determine the
plasma membrane location of phosphorylated proteins, B
cells were untreated or treated with anti-Ig at 48C and
warmed to 378C for 0, 10, or 30 min. At the end of each
time point, the cells were lysed in 1% Triton X-100 lysis
buffer and subjected to discontinuous sucrose density gradi-
ent centrifugation. The gradient fractions were analyzed by
SDS-PAGE and immunoblot probing for phosphotyrosine-
containing proteins using the phosphotyrosine-specific re-
combinant antibody RC20H. In the absence of cross-linking,
phosphorylated proteins are present in the Triton X-100–
soluble membrane fractions, and only faint bands of phos-
Figure 1. BCR cross-linking results in translocation of the BCR into
GM1-containing lipid rafts. CH27 cells were surface biotinylated at 48C
and incubated with anti-Ig on ice for 15 min. The cells were warmed for
0 or 30 min and lysed in 1% Triton X-100 in TNEV buffer. The lysates
were subjected to discontinuous sucrose density gradient centrifugation,
and 1-ml fractions were collected. To determine the location of lipid rafts
in the gradient, 100 ml of the individual fractions were subjected to 10%
SDS-PAGE. After transfer onto PVDF, the membranes were probed for
the presence of m heavy chain and Iga using specific antibodies. The gan-
glioside GM1 was detected using CTB–HRP. To determine the location
of surface BCR in the gradient, biotinylated proteins were immunopre-
cipitated from the gradient fractions using streptavidin–agarose. The im-
munoprecipitates were subjected to 10% SDS-PAGE and immunoblot
probing with antibodies specific for Ig and Iga detected with HRP-con-
jugated secondary antibodies and ECL. Representative blots of three sep-
arate experiments are shown.
Figure 2. The kinase Lyn is constitutively present and the phosphatase
CD45R is excluded from rafts in B cells. CH27 cells were treated with
anti-Ig at 48C for 15 min, washed, and warmed for 0 or 30 min at 378C.
The cells were lysed in 1% Triton X-100 in TNEV, and lysates were sub-
jected to discontinuous sucrose gradient centrifugation. Fractions from
the gradient were subjected to 10% SDS-PAGE and transferred to PVDF.
To determine the positions in the gradient of Lyn, CD45R, H2-M, actin,
and tubulin, the membranes were probed with specific antibodies fol-
lowed by HRP-conjugated secondary antibodies and ECL. Shown are
representative blots of three separate experiments.1553 Cheng et al.
phorylated proteins can be detected in the lipid raft region
of the gradient (Fig. 3), reflecting the constitutive level of
protein tyrosine phosphorylation in CH27 cells. Upon BCR
cross-linking, the intensity and number of phosphorylated
proteins increase immediately in the fractions that contain
detergent-soluble and -insoluble membranes and then re-
turn to the levels present in unactivated cells by 30 min. To
determine if the phosphorylated proteins in the lipid rafts
include either Iga or Lyn, immunoblots were reprobed
with antibodies specific for Iga and Lyn. As shown, the Iga
band at 34 kD and the Lyn bands at 53 and 56 kD align
with phosphotyrosine-containing proteins (Fig. 3). By im-
munoblotting, Lyn appears to be present in the lipid rafts
in approximately the same amount in untreated and anti-
Ig–treated cells throughout the 30-min chase; however, the
phosphorylation state of Lyn appears to change with BCR
cross-linking. Iga enters the raft after BCR cross-linking,
with maximal translocation occurring 10 min after BCR
cross-linking; by 30 min, the amount of Iga in lipid rafts
decreases. At each time point, the Iga present in the raft re-
gion appears to be phosphorylated. It is difficult to deter-
mine if Lyn and Iga phosphorylation is restricted to the
lipid rafts because of the complexity of the pattern of phos-
phorylated proteins in the Triton X-100–soluble fractions,
although there are no obvious phosphoproteins aligning
with Iga and Lyn. Taken together, these results suggest that
after cross-linking, the BCR enters the lipid rafts, where
the Lyn kinase is concentrated to facilitate initiation of sig-
nal cascades, including Iga and Lyn phosphorylation. The
exclusion of CD45R from the lipid rafts indicates that only
BCRs outside the lipid rafts would be targets of CD45R
phosphatase activity.
Antigen Bound to the BCR Is Rapidly Translocated to Lipid
Rafts after BCR Cross-linking. The results described above
provide evidence that upon cross-linking, the BCR rapidly
translocates into lipid rafts. To verify that the BCR that
moved into lipid rafts was the BCR bound to anti-Ig as a
surrogate antigen, B cells were untreated or treated with
HRP–anti-Ig at 48C for 15 min, washed, and warmed at
378C for 0, 15, or 30 min. The cells were lysed in 1% Triton
X-100 lysis buffer and subjected to discontinuous sucrose
gradient centrifugation, and the HRP activity in the gradi-
ent fractions was measured (Fig. 4 A). In untreated cells,
there was little endogenous peroxidase activity detected in
the lipid raft region of the gradient, and a small amount of
endogenous peroxidase activity was detected in the soluble
membrane fractions at the bottom of the gradient. In HRP–
anti-Ig–treated cells, HRP activity was found to be highly
concentrated in the lipid raft regions immediately after
warming to 378C. There appears to be a slight increase in
the HRP activity in the lipid raft regions 15 min after warm-
ing to 378C and a small decrease in HRP activity after 30
min. However, the enzyme activity was not measured in a
quantitative fashion, so the small differences may not be
significant.
To gain a more quantitative measure of the translocation
of the antigen bound to the BCR into lipid rafts, B cells
were incubated for 1 h with monovalent 125I–Fab–anti-Ig
and subsequently left untreated or treated with rabbit anti–
mouse Ig and warmed to 378C for 0–30 min (Fig. 4 B). In
the absence of cross-linking, z12% of the 125I–Fab–anti-Ig
is located in lipid rafts. After cross-linking, this percentage
increases to z26% and then decreases to 18% by 30 min af-
ter cross-linking. The presence of the 12% of 125I–Fab in
Figure 3. Phosphorylated Iga and Lyn are present in lipid rafts after
BCR cross-linking. CH27 cells were untreated or incubated with anti-Ig
for 30 min at 48C and warmed to 378C for 0, 10, or 30 min. Cells were
lysed in 1% Triton X-100 in TNEV buffer and subjected to discontinu-
ous sucrose density gradient centrifugation. Right panels: gradient frac-
tions were subjected to SDS-PAGE and immunoblot probing with the
HRP-conjugated, phosphotyrosine-specific recombinant Ab RC20H and
visualized by ECL. Left panels: immunoblots were treated with 0.02% so-
dium azide to inhibit RC20H enzyme activity, reprobed with Iga- and
Lyn-specific mAbs, and detected using HRP-conjugated secondary anti-
bodies and ECL. Shown are the immunoblots from fraction 4. Represen-
tative blots of three separate experiments are shown.1554 Role for Lipid Rafts in B Cell Receptor Signaling and Antigen Targeting
the lipid rafts in unactivated cells, even though sIg and Iga
were not detected in lipid rafts by immunoblotting (Fig. 1),
suggests that the 125I–Fab–anti-Ig preparation likely contained
some aggregated Fab–anti-Ig or F(ab9)2–anti-Ig capable of
cross-linking the BCR. Nevertheless, the increase in the
percentage of 125I–Fab–anti-Ig in rafts after anti-Ig treat-
ment correlated with the translocation of biotinylated sIg
and Iga and HRP–anti-Ig into lipid rafts.
BCR Cross-linking Triggers the Targeting of GM1 to the
IIPLC. Using a nondisruptive chemical cross-linking tech-
nique, we previously showed that upon cross-linking the
BCR is rapidly targeted from the plasma membrane through
TfR-containing early endosomes to the IIPLC (45). To de-
termine if the BCR remains associated with components of
the lipid raft during intracellular targeting, the same chemi-
cal cross-linking technique was used to follow the intra-
cellular movement of the lipid raft ganglioside GM1 in
untreated B cells and in B cells treated with anti-Ig. CTB–
HRP was used to label GM1 at the B cell surface at 48C and
to follow the movement of GM1 into the cell. Any protein
present in the same compartment as CTB–HRP will be
polymerized into insoluble aggregates in the presence of
membrane-soluble DAB and H2O2 but not in the absence
of H2O2. The insoluble polymers can be removed by cen-
trifugation, and thus the absence of a protein in the lysate
indicates its presence in CTB–HRP-containing compart-
ments. As detailed elsewhere, the HRP-mediated polymer-
ization of proteins depends on the presence of the protein,
HRP, DAB, and H2O2 in the same subcellular compart-
ment, and nonspecific, promiscuous polymerization of pro-
teins outside HRP-containing compartments is not observed
(9, 45). The movement of GM1 from the plasma membrane
into early endosomes and to the IIPLC was followed. To de-
tect the movement of CTB–HRP into early endosomes,
the TfR was monitored. TfR has been shown by others to
be excluded from lipid rafts (35). B cells were surface biotin-
ylated and incubated at 48C with CTB–HRP in the pres-
ence or absence of anti-Ig. The cells were washed and
warmed to 378C for varying lengths of time up to 120 min.
At the end of each time point, the cells were exposed to
the chemical cross-linking reagent DAB in the presence or
absence of H2O2 and lysed, and the lysates were centri-
fuged to remove insoluble polymers. TfR was immunopre-
cipitated from the cleared lysate and subjected to SDS-PAGE
and immunoblot probing for biotinylated proteins using
streptavidin–HRP. In cells in which the BCR was not cross-
linked, CTB–HRP briefly contacts z50% of TfRs after
warming to 378C and by 30 min is in contact with a steady
state level of z20% of the biotinylated TfRs (Fig. 5). Be-
cause it is difficult to rule out the presence of aggregated or
multimerized CTB in the CTB–HRP conjugate prepara-
tion, it is not possible to be certain that the observed con-
tact of the CTB–HRP with TfR reflects the constitutive be-
havior of GM1 or whether the contact with TfR is induced
by aggregated CTB–HRP. In B cells in which the BCR is
cross-linked, CTB–HRP appears to contact more of the
TfR upon warming to 378C (.90%) and to stay in contact
with the TfR longer (.60 min) before returning to steady
state levels of 20% by 120 min. The kinetics of contact of
CTB–HRP with the TfR after BCR cross-linking are sim-
ilar to those previously observed for BCR contact with the
TfR after BCR cross-linking (45).
To determine if any GM1 is targeted to the IIPLC, B cells
were pulsed for 15 min with [35S]methionine in the pres-
ence of CTB–HRP and in the presence or absence of anti-
Ig. The cells were washed, warmed to 378C, and chased for
60–180 min. Times were selected that allowed for the de-
tection of newly assembled class II molecules that first bind
peptide and adopt SDS-stable conformation in the IIPLC,
z60–90 min after synthesis (9, 46). At the end of each chase
time, the cells were treated with DAB in the presence or
absence of H2O2 to cross-link proteins present in the same
compartment as the CTB–HRP. The lysates were centri-
fuged to remove insoluble cross-linked polymers, and class
II molecules were immunoprecipitated from the cleared ly-
sate. In untreated B cells, SDS-stable class II heterodimers
first appear faintly at 60 min of chase and continue to in-
crease over 150 min and then decrease by 180 min as the
Figure 4. BCR-bound antigens translocate into rafts after BCR cross-
linking. (A) B cells were untreated (02) or treated with HRP–anti-Ig at
48C for 1 h, washed, and warmed to 378C for 0, 15, or 30 min (01, 151,
and 301, respectively). The cells were lysed in 1% Triton X-100 in
TNEV buffer, the lysates subjected to discontinuous sucrose density gra-
dient centrifugation, and the fractions assayed for HRP activity. (B)
CH27 cells were incubated at 48C for 1 h with 125I–Fab–anti-Ig. During
the last 30 min of incubation, the cells were untreated (02) or treated
with anti-Ig to cross-link the BCR and then warmed to 378C for 0–30
min (01 to 301). The cells were lysed in 1% Triton X-100 in TNEV
buffer, the lysates were subjected to discontinuous sucrose gradient cen-
trifugation, and the cpm of each fraction was measured and expressed as a
percent of the total cell-associated 125I. The average and SEM of three in-
dependent experiments is shown.1555 Cheng et al.
class II molecules exit the IIPLC and traffic to the plasma
membrane (Fig. 6). The intense band above the class II a/b
dimers present at 60 min and decreasing thereafter has been
previously determined to contain Ii dimers. Significantly,
the amount of SDS-stable class II molecules formed was
equivalent at each time point in the presence or absence of
H2O2 (Fig. 6), indicating that CTB–HRP was not present
in the peptide loading compartment. In contrast, in B cells
in which the BCR was cross-linked, the number of SDS-
stable class II molecules was decreased in the presence of
H2O2 beginning after 90 min of chase time. The reduction
of SDS-stable class II molecules was maximal (z30%) at
120–150 min and less by 180 min as class II molecules ex-
ited the peptide loading compartment.
Taken together, these results indicate that in unactivated
B cells, the CTB–HRP bound to GM1 briefly enters early
endocytic TfR-containing compartments but is not tar-
geted to the late IIPLC. Cross-linking the BCR, which, as
shown previously, results in BCR targeting to the IIPLC
(9, 45), results in a concomitant targeting of GM1-bound
CTB–HRP to the IIPLC. GM1 appears to stay in contact
with the BCR en route to the IIPLC, as shown by the abil-
ity of CTB–HRP to cause Iga polymerization throughout
the chase period (data not shown). Thus, the BCR appears
to remain associated with a portion of the lipid raft GM1 as
the BCR is targeted to the IIPLC.
The GPI-linked Ig Mutant mCytoD Is Constitutively Con-
centrated in Lipid Rafts but Is Not Targeted to the IIPLC. The
results presented above showed that the BCR is excluded
from lipid rafts in unactivated cells and upon cross-linking
is translocated into lipid rafts and targeted to the IIPLC. The
targeting of the BCR to the IIPLC was accompanied by the
movement of a portion of the lipid raft GM1 to the IIPLC.
To determine the relationship between residency of a re-
ceptor in lipid rafts and targeting to the IIPLC, we analyzed
a human Ig, mCytoD, in which the cytoplasmic domain was
deleted. Previous characterization showed that mCytoD
stably transfected into mouse A20 cells (A20mCytoD) is ex-
pressed as a GPI-linked protein that does not associate with
the Iga/Igb complex (13, 14). As a GPI-linked protein,
mCytoD is predicted to reside in lipid rafts. The behavior of
mCytoD was compared with that of the endogenous mouse
Ig in A20mCytoD cells and to that of a WT human Ig (mWT)
in A20mWT cells. By flow cytometry, both mCytoD (cyto-
plasmic tail deletion) and mWT are expressed at levels sim-
ilar to that of the endogenous mouse Ig in both cell lines
(Fig. 7 A). The staining is specific, and the cells do not stain
using FITC-labeled antibodies specific for the human g chain.
The cell surface expression of mCytoD as a GPI-linked
protein was verified by PI-PLC treatment of biotinylated
cells followed by immunoprecipitation of human IgM and
immunoblot analysis, probing for biotinylated proteins.
Upon treatment with PI-PLC, mCytoD is released into the
supernatant, in contrast to mWT, which remains cell asso-
ciated (Fig. 7 B).
The lipid raft localization of mCytoD, mWT, and en-
dogenous mouse IgG was determined using HRP-conju-
gated antibodies as described above. In brief, A20mCytoD
Figure 5. BCR cross-linking results in CTB–HRP internalization into
TfR-positive early endosomes. (A) CH27 cells were surface biotinylated,
incubated at 48C with CTB–HRP in the presence or absence of anti-Ig,
and chased for various times. At the end of each time point, the cells were
incubated with DAB in the presence or absence of H2O2 and lysed in
RIPA lysis buffer, and insoluble polymers were removed by centrifugation.
TfR was immunoprecipitated from the lysate supernatants and subjected to
10% SDS-PAGE and immunoblot probing for biotinylated proteins using
streptavidin–HRP and ECL. (B) The TfR bands from at least three separate
experiments were quantified by densitometry, and the average amounts of
TfR were normalized to the amount present in cells at 0 min treated with
DAB without H2O2. (C) The amounts of TfR presented in B are shown as
percent reduction in DAB-reacted cells at each time point.1556 Role for Lipid Rafts in B Cell Receptor Signaling and Antigen Targeting
or A20mWT cells were untreated or incubated with HRP-
conjugated antibodies specific for either mouse IgG or hu-
man IgM for 1 h at 48C. The cells were washed and warmed
to 378C for 30 min, lysed in 1% Triton X-100 lysis buffer,
and subjected to discontinuous sucrose density gradient
centrifugation. The HRP activity in the individual gradient
fractions was measured. The endogenous peroxidase activity
in the untreated cells is low in the lipid raft region of the
gradient and only slightly higher in the soluble membrane
fractions at the bottom of the gradient (Fig. 8 A). The HRP-
coupled antibodies specific for the endogenous mouse IgG
were present in both the lipid raft region of the gradient
and the soluble membrane region at the bottom of the gra-
dient. The behavior of mWT was similar to that of mouse
IgG after HRP–anti-Ig treatment, distributing both in the
raft region and in the detergent-soluble region of the su-
crose gradient (Fig. 8 A). These patterns were similar to
that observed for mouse IgM in CH27 cells. In contrast,
HRP-conjugated antibodies specific for human IgM in
A20mCytoD cells were located exclusively in the lipid raft
region of the gradient.
To independently confirm the location of mCytoD with
regard to lipid rafts, A20mCytoD cells were either un-
Figure 6. BCR cross-linking results in CTB–HRP targeting to the
class II peptide loading compartment. (A) CH27 cells were labeled with
[35S]methionine for 15 min in the presence of CTB–HRP and in the
presence or absence of anti-Ig and chased for 60–180 min. At the end of
each time point, the cells were treated with DAB in the presence or ab-
sence of H2O2 and lysed in 1% Triton X-100 lysis buffer, and insoluble
polymers were removed by centrifugation. The I-Ek class II molecules
were immunoprecipitated from the lysate and subjected to SDS-PAGE
without boiling or reducing the samples, conditions under which pep-
tide-bound class II a/b dimers are stable. (B) The a/b dimer bands of at
least three independent experiments were quantified by densitometry,
and the average amounts for each chase time are shown as the percent of
the total amount of SDS-stable class II immunoprecipitated from all time
points. (C) The amount of SDS-stable class II presented in B is shown as
the percent reduction in DAB-reacted cells at each time point.
Figure 7. Cytoplasmic tail deletion Ig mutation is expressed on the cell
surface as a GPI-linked protein. (A) A20mCytoD and A20mWT cells
were analyzed by flow cytometry using FITC-labeled antibodies specific
for mouse IgG, human IgG, and human IgM (gray shaded areas). Also
shown as controls are the stainings of human 114 cells with FITC-labeled
anti–mouse IgG and nontransfected A20 cells with FITC-labeled anti–
human IgG and anti–human IgM (black shaded areas). (B) Cells were sur-
face biotinylated and untreated or treated with PI-PLC at 378C for 1 h.
Solubilized proteins in the supernatant and lysates from the cell pellets
were immunoprecipitated for human Ig, and the immunoprecipitates
were subjected to 10% SDS-PAGE and immunoblot probing for biotiny-
lated proteins using streptavidin–HRP and ECL.1557 Cheng et al.
treated or incubated with antibodies specific for mouse IgG
or human IgM at 48C for 1 h, washed, and incubated at
378C for 30 min. The cells were lysed in 1% Triton X-100
in TNEV buffer and fractionated on a discontinuous su-
crose gradient, and the fractions were subjected to SDS-
PAGE and immunoblot probing for either mouse IgG or
human IgM. The mouse IgG is not present in the lipid raft
region of the gradient in unactivated A20mCytoD cells
(Fig. 8 B), and upon cross-linking, mouse IgG translocates
to the lipid rafts. This result is similar to that described
above for mouse IgM in CH27 cells and indicates that the
heavy chain isotype of the sIg does not influence its behav-
ior with regard to lipid raft localization. In cells treated
with antibodies specific for human IgM, mouse IgG re-
mains excluded from the lipid raft region. Thus, cross-link-
ing mCytoD had no effect on endogenous mouse IgG. In
contrast to the behavior of  endogenous mouse IgG, hu-
man mCytoD is found nearly exclusively in the lipid raft re-
gion in unactivated cells (Fig. 8 B). Upon cross-linking us-
ing antibodies specific for human IgM, the position of
mCytoD in lipid rafts does not change. Moreover, the
cross-linking and translocation of the mouse IgG into lipid
rafts does not alter the position of mCytoD.
To determine if the inclusion of mCytoD in the buoyant
fractions was dependent upon the integrity of the lipid rafts
and to determine if aggregation of the receptor alone dictates
its behavior on sucrose gradients, A20mCytoD cells were
treated with anti-Ig and the cholesterol-sequestering drug
methyl-b-cyclodextrin that disrupts cholesterol-dependent
rafts. In cyclodextrin-treated cells, mCytoD is no longer
present in the buoyant region of the sucrose gradient but
rather in the Triton X-100–soluble dense region of the gra-
dient, even in the presence of cross-linking antibody (Fig. 9).
The effect of cyclodextrin was partially reversible after 3 h
with the addition of cholesterol (Fig. 9). Taken together, these
results indicate that the localization in buoyant regions of the
sucrose gradient is dependent on the integrity of the lipid rafts,
and aggregation of sIg with anti-Ig alone does not result in ap-
pearance of the sIg in the buoyant gradient functions.
To determine if the mCytoD is targeted to the IIPLC after
cross-linking, A20mCytoD cells were pulsed with [35S]methi-
onine for 15 min in the presence of HRP-conjugated anti-
bodies specific for either mouse IgG or human IgM. The
cells were washed and incubated for 60–180 min at 378C.
At the end of each time point, the cells were treated with
DAB in the presence or absence of H2O2 and lysed, and the
I-Ad class II molecules were immunoprecipitated. The im-
munoprecipitates were subjected to SDS-PAGE without
reducing or boiling the samples, conditions under which
peptide-bound class II a/b dimers are stable. In cells treated
with HRP–anti–mouse IgG, the number of class II a/b
dimers is decreased after treatment with DAB plus H2O2 as
compared with DAB alone (Fig. 10). The reduction in class
II molecules is observed at 60 min, reaches a maximum of
40% at 120 min, and decreases thereafter as the class II mol-
ecules exit the IIPLC. Similar results were obtained by ana-
Figure 8. Cytoplasmic tail deletion mutants of sIg are localized in lipid
rafts in resting cells. (A) A20mCytoD and A20mWT cells were incubated
with HRP-conjugated rabbit anti–human IgM or goat anti–mouse IgG
for 1 h at 48C, washed, and chased for 30 min. The cells were then lysed
in 1% Triton X-100 in TNEV buffer, and the lysates were subjected to
discontinuous sucrose density gradient centrifugation. Fractions were col-
lected and HRP activity measured. Shown are untreated A20mCytoD
(d), A20mCytoD treated with HRP–anti–human Ig (j) or HRP–anti–
mouse Ig (r), and A20mWT treated with HRP–anti–human Ig (m).
Shown is a representative experiment of three independent experiments.
(B) A20mCytoD cells were treated with either anti–human IgM or anti–
mouse IgG at 48C for 1 h, washed, and warmed to 378C for 30 min. The
cells were lysed in 1% Triton X-100 in TNEV buffer and subjected to
discontinuous sucrose gradient centrifugation. The gradient fractions
were analyzed by 10% SDS-PAGE and immunoblot probing with either
mouse IgG– or human IgM–specific antibodies and ECL.
Figure 9. Disruption of lipid rafts results in the reversible loss of
mCytoD from the detergent-insoluble region of the sucrose gradient.
A20mCytoD cells were untreated or pretreated with 12.5 mM methyl-
b-cyclodextrin for 20 min at 378C and washed to remove drug–choles-
terol complexes. Half of the cells were removed and placed in 15% CM
for 3 h to allow for cholesterol recovery. Cells were then treated with anti–
human IgM, lysed in 1% Triton X-100 in TNEV, and subjected to dis-
continuous sucrose gradient centrifugation. Fractions were analyzed by
10% SDS-PAGE and immunoblot probing with HRP-labeled human
IgM–specific antibodies and ECL. Shown are representative blots from
three independent experiments.1558 Role for Lipid Rafts in B Cell Receptor Signaling and Antigen Targeting
lyzing mWT in A20mWT cells using HRP–anti–human IgM,
in which case 25% of newly synthesized SDS-stable class II
molecules were cross-linked after 120 min of chase time.
These results are in agreement with those previously shown
for the contact of WT IgM BCR with newly synthesized
I-Ek in CH27 cells (9, 45). In contrast, in A20mCytoD cells
treated with HRP–anti–human IgM, there was no reduc-
tion in the number of class II molecules in cells treated with
DAB plus H2O2 as compared with DAB alone (Fig. 10).
Moreover, in A20mCytoD cells treated with antibodies spe-
cific for mouse IgG and HRP-conjugated antibodies specific
for human IgM, mCytoD was not targeted to the IIPLC
(data not shown). Thus, mCytoD resident in the lipid raft did
not accompany the WT mouse BCR to the IIPLC. These
findings indicate that the human IgM that constitutively re-
sides in the lipid rafts is not targeted to the IIPLC after cross-
linking, in agreement with previous results showing that the
mCytoD did not target antigen for class II processing (15).
Moreover, these results indicate that residency in the lipid
rafts region alone is not sufficient for targeting to the IIPLC.
Discussion
The BCR plays two key roles in the B cell response to
antigen. The first is to transmit signals through several intra-
cellular pathways that ultimately dictate the fate of the B
cell’s encounter with antigen (1–3). BCR signaling itself
has been recently appreciated to be a complex phenome-
non that is directly influenced both positively and negatively
by B cell coreceptors, including CD19/CD21, CD22,
CD40, and FcgRIIB (1). How the components of the BCR
signaling cascade and the coreceptors are organized on the
plasma membrane to affect the final outcome is not known.
In addition to signaling, the BCR physically transports an-
tigen from the cell surface to the IIPLC (6). The current
evidence indicates that the signaling function of the BCR is
required to specify both the targeting of the BCR to the
IIPLC and the rate at which the targeting is achieved.
How the signaling and targeting functions of the BCR
are coordinated is not known. In this report, we show that
after cross-linking, the BCR is rapidly translocated into
lipid rafts that contain the Src family kinase Lyn, a key ki-
nase in the initiation of the BCR signal transduction cas-
cade, and exclude the phosphatase CD45R. Moreover, we
show that phosphorylated Iga and Lyn are present in the
lipid rafts after BCR cross-linking. Taken together, these
results suggest that the recruitment of the BCR to the lipid
rafts may represent an important, previously unappreciated
event in BCR signaling, allowing the concentration of the
BCR and the enzymes and adaptors of the signaling pathway.
Upon BCR cross-linking, it has been observed that sIg
becomes associated with the actin cytoskeleton and that cyto-
skeletal attachment is not dependent on Iga/b signaling
(47). Furthermore, sIg with cytoplasmic tail sequence KVK
replaced with the Iga tail was shown to have reduced abil-
ity to associate with cytoskeletal actin (48). Although the sig-
nificance of cytoskeletal attachment remains unknown, we
provide evidence that the WT BCR translocated into the
lipid raft, along with the raft component GM1, is subse-
quently targeted to the IIPLC in an accelerated fashion. Thus,
the lipid raft may provide components necessary for the cor-
rect and accelerated targeting of the BCR to the IIPLC. Our
result showing that mCytoD is constitutively localized in
lipid rafts but is not targeted to the IIPLC suggests that raft
localization alone is not sufficient for efficient internaliza-
tion and proper intracellular targeting. Targeting may re-
quire initiation of signaling, a function for which mCytoD is
deficient. However, rafts may provide a means for efficient
Figure 10. Upon cross-linking, mCytoD is not targeted to the IIPLC.
(A) A20mCytoD cells were labeled with [35S]methionine for 15 min in
the presence of either HRP-conjugated anti–human IgM or anti–mouse
IgG, washed, and chased for 60–180 min. At the end of each chase time,
the cells were treated with DAB in the presence or absence of H2O2 and
lysed in 1% Triton X-100 lysis buffer. I-Ad class II molecules were immu-
noprecipitated, analyzed by 10% SDS-PAGE without reducing or boiling
the samples, and visualized by autoradiography. (B) The class II a/b
dimer bands from three separate experiments were quantified by densitom-
etry, and the average amounts for each chase time are shown as the per-
cent total SDS-stable class II dimers immunoprecipitated from all time
points. (C) The amounts of SDS-stable class II presented in B are shown
as the percent reduction in DAB-reacted cells at each time point.1559 Cheng et al.
cytoskeletal association of sIg either directly or through as-
sociated factors. Taken together, the results presented here are
consistent with the hypothesis that lipid rafts serve as platforms
for both signaling and trafficking of membrane receptors (16).
The molecular mechanisms by which the BCR is trans-
located to lipid rafts remain to be elucidated. The translo-
cation of the BCR to lipid rafts was nearly instantaneous
after cross-linking. The rapidity of the translocation was
similar to that reported by Montixi et al. (36), who showed
that the engagement of the TCR triggers an immediate ac-
cumulation of the TCR and protein tyrosine kinases to
lipid rafts, readily detectable within 10 s. Cross-linking the
BCR may result in a conformational change of some sort
in the BCR that allows its rapid translocation into lipid rafts
by destabilizing its interaction with Iga/Igb or the replace-
ment of Iga/Igb by some other membrane component.
Indeed, Vilen et al. (49) recently provided evidence that af-
ter antigen binding, the sIg–Iga/Igb complex is destabi-
lized such that Iga/Igb no longer coimmunoprecipitates
with sIg. However, the results presented here show that
both sIg and Iga enter the rafts, indicating that the BCR
remains intact after cross-linking. A conformational change
could also be the result of a specific phosphorylation event
on one of the tyrosines within the Iga/Igb ITAMs. Pre-
sumably, such a phosphorylation event is insufficient to ini-
tiate significant downstream signaling before translocation
to the lipid rafts. The current evidence concerning the
mechanism of the translocation of the TCR into lipid rafts
upon TCR engagement suggests that phosphorylation of
the TCR outside the lipid rafts promotes translocation. Al-
ternatively, a conformational change could be induced by
the clustering or aggregation of the BCR by cross-linking.
Analysis of additional BCR constructs in which both the
association of sIg with Iga and Igb and the signaling poten-
tial of the Iga/Igb complex are altered should be informa-
tive with regard to the molecular basis of the trigger that
leads to BCR translocation.
The BCR is similar to two other immune receptors in its
behavior on the plasma membrane after cross-linking, namely
the TCR and the IgE receptor, both of which become con-
centrated in lipid rafts after engagement. Given that these re-
ceptors share many common features in terms of the processes
by which signal transduction cascades are initiated and regu-
lated, the observation that similar strategies are used to allow
concentration of the components of the signaling cascade is
perhaps not surprising. As the composition of the lipid rafts is
further characterized and the molecular mechanism underly-
ing the triggering of these receptors to translocate to lipid rafts
is defined, there are likely to be more commonalities discov-
ered as well as interesting differences revealed.
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